Michael Repka
Director of the PII Center for Pharmaceutical Technology Distinguished Professor of Pharmaceutics and Drug Delivery and Research Professor in the Research Institute of Pharmaceutical Sciences
Dr. Michael A. Repka is the Distinguished Professor of Pharmaceutics & Drug Delivery and Director of the Pii Center for Pharmaceutical Technology. Professor Repka received his B.S. in Pharmacy and Ph.D. in Pharmaceutical Sciences with an emphasis in Pharmaceutics from the University of Texas at Austin. In addition, he earned his D.D.S. from the University of Texas Health Science Center at San Antonio. From a research perspective, Dr. Repka has over 30 years of experience utilizing hot-melt extrusion (HME) for pharmaceutical dosage forms and devices, as well as 3D Printing.
Research Interests
- Hot-melt extrusion for poorly soluble drug delivery.
- 3D Printing for advancement of novel patient focused drug delivery for the pediatric, geriatric and special needs patient population.
- Melt granulation using continuous advanced manufacturing.
Biography
Dr. Michael A. Repka received his B.S. in Pharmacy and Ph.D. in Pharmaceutical Science with an emphasis in Pharmaceutics from the University of Texas at Austin. He serves as the Distinguished Professor of the Department of Pharmaceutics & Drug Delivery and Director of the Pii Center for Pharmaceutical Technology at The University of Mississippi. Dr. Repka’s research primarily focuses on enhancing solubility and bioavailability of poorly soluble drugs via hot‐melt extrusion (HME) technology, with novel dosage forms as a common denominator. He has over 30 years’ experience with HME for pharmaceutical dosage form and device advanced manufacturing. In addition, Dr. Repka has utilized HME for patient centric delivery to pediatric, geriatric, and special needs patients. This focus led him to employ 3D printing (Fused Deposition Modeling) to further advance development and delivery of patient focused complex dosages. Furthermore, polymeric drug delivery design and stabilization, formulation, and process development for natural products, antifungal/antibacterial/immunostimulant agents are also important components of his research.
Dr. Repka has published over 250 peer-reviewed articles in prestigious pharmaceutical journals. He also serves on the Editorial Advisory Boards of six prominent journals. In addition, he is an Editor for AAPS PharmSciTech and was Associate Editor for Journal of Drug Delivery Science and Technology for over 10 years. He has received various honors including an AAPS Fellow Award, Distinguished Professor designation, and the Distinguished Research and Creative Achievement Award (The University of Mississippi’s highest research award). Recently at the 2023 AAPS meeting in Orlando, FL, he received the Ralph Shangraw Memorial Award from the International Pharmaceutical Excipients Council. Dr. Repka regularly presents at national and international HME/3D Printing and formulation symposia/workshops as an invited speaker >80 times over the last 10 years.
Education
B.S. Pharmacy, University of Texas at Austin (1976)
Other Dental Surgery, University of Texas San Antonio (1981)
Ph.D. Pharmaceutical Science, University of Texas at Austin (2000)